Full year 2024 sales of $4.4 billion represents ATI’s highest total since 2012 Q4 2024 sales of $1.2 billion, up 10% over Q4 2023; full year 2024 sales of $4.4 billion, up 5% over full year 2023 Q4 2024 net income attributable to ATI of $137 million, or $0.94 per share; full year 2024 net…
Tag: PR Newswire
NEWARK, N.J., Feb. 4, 2025 /PRNewswire/ — Public Service Enterprise Group Incorporated (PSEG) will host its fourth quarter and full year 2024 earnings call at 11:00 a.m. ET on Tuesday, February 25, during which management will discuss fourth quarter and year end financial results,…
PRINCETON, N.J., Feb. 4, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company…
Strategic Collaboration and Reverse Takeover: DeFi Technologies has entered a binding letter agreement with CoreFi Strategy and Orinswift Ventures to facilitate a reverse takeover, enabling the listing of the resulting issuer’s common shares on the Cboe Canada Stock Exchange (Cboe). Core…
NEW YORK, Feb. 4, 2025 /PRNewswire/ — Madison Square Garden Sports Corp. (NYSE: MSGS) today reported financial results for the fiscal second quarter ended December 31, 2024. During the fiscal 2025 second quarter, the New York Knicks (“Knicks”) and New York Rangers (“Rangers”) began their…
PALO ALTO, Calif., Feb. 4, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that senior management will…
CUPERTINO, Calif., Feb. 4, 2025 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that James E. Brown, President and Chief Executive Officer, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference, to be held virtually, February 11-12, 2025….
Backlog Grows by 18.9% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x Repurchased $202 Million of our Shares During Q1 Board Authorizes $1.5 Billion for Company’s Largest Ever Share Repurchase Program Increasing Dividend to $0.32/share, a 10% Increase Year-Over-Year Raising FY 2025…
From ‘Ozempic Face’ to Facelifts, Fat Grafting, Male Procedures, and Regenerative Medicine WASHINGTON, Feb. 4, 2025 /PRNewswire/ — The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), the world’s largest association of facial plastic and reconstructive surgeons,…
Expands and Extends Integrated NGL Value Chain TULSA, Okla., Feb. 4, 2025 /PRNewswire/ — ONEOK, Inc. (NYSE: OKE) and MPLX LP (NYSE: MPLX) have entered into definitive agreements to form joint ventures to construct a new large-scale 400,000-barrel per day (bpd) liquefied petroleum gas…